FindTrial
Sign In

Whole clotting assessment as predictor of clinical phenotype in aged patients with haemophilia A

Whole clotting assessment as predictor of clinical phenotype in aged patients with haemophilia A - HAEMOTYPE-AGING study

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON37558
Enrollment
12
Registered
2012-05-15
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

haemophilia

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - male; - patients aged > 60 years with haemophilia A; - patients aged between 20-30 years with haemophialia A; - patients known at the Haemophilia Center of the Academic Medical Center; - patients who visit the Haemophilia Center for routine blood testing (inhibitor testing); - patients whose age of first bleeding and bleeding frequency have been recorded; - only if written informed consent from patient is given.

Exclusion criteria

Exclusion criteria: - patients with an inhibitor in the past; - administration FVIII concentrate

Design outcomes

Primary

MeasureTime frame
Clinical parameters: - age of first bleeding, - extent of arthropathy Laboratory parameters: - result ETP/TM-ETP (lag time, peak thrombin, area under the curve) - result T-TAS (time to occlusion, occlusion time, occlusion speed, area under the curve)—

Secondary

MeasureTime frame
n.v.t.—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)